Sino Biopharmaceutical Limited
SBMFF
$0.9891
$0.03914.12%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -3.90% | 16.48% | -0.64% | -8.33% | 2.90% |
| Total Receivables | -3.90% | -4.29% | -0.64% | 16.61% | 2.90% |
| Inventory | -3.90% | 33.81% | -0.64% | -9.49% | 2.90% |
| Prepaid Expenses | -3.90% | -74.72% | -0.64% | 379.58% | 2.90% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 2.90% |
| Total Current Assets | -3.90% | 1.39% | -0.64% | 4.05% | 2.90% |
|
|
|||||
| Total Current Assets | -3.90% | 1.39% | -0.64% | 4.05% | 2.90% |
| Net Property, Plant & Equipment | -3.90% | 10.13% | -0.64% | -4.12% | 2.90% |
| Long-term Investments | -3.90% | 35.33% | -0.64% | 1.17% | 2.90% |
| Goodwill | -3.90% | 35.33% | -0.64% | 1.17% | 2.90% |
| Total Other Intangibles | -3.90% | -88.37% | -0.64% | 857.35% | 2.90% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -3.90% | 137.25% | -0.64% | -66.96% | 2.90% |
| Total Assets | -3.90% | 1.59% | -0.64% | 2.99% | 2.90% |
|
|
|||||
| Total Accounts Payable | -3.90% | -29.20% | -0.64% | 61.22% | 2.90% |
| Total Accrued Expenses | -3.90% | -- | -- | -- | 2.90% |
| Short-term Debt | -- | -- | -- | -- | 2.90% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -3.90% | -7.13% | -0.64% | -25.41% | 2.90% |
| Total Finance Division Other Current Liabilities | -3.90% | -74.41% | -0.64% | 243.76% | 2.90% |
| Total Other Current Liabilities | -3.90% | -74.41% | -0.64% | 243.76% | 2.90% |
| Total Current Liabilities | -3.90% | -7.70% | -0.64% | -4.65% | 2.90% |
|
|
|||||
| Total Current Liabilities | -3.90% | -7.70% | -0.64% | -4.65% | 2.90% |
| Long-Term Debt | -3.90% | 104.81% | -0.64% | -7.68% | 2.90% |
| Short-term Debt | -- | -- | -- | -- | 2.90% |
| Capital Leases | -3.90% | -44.14% | -0.64% | -49.10% | 2.90% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -3.90% | -29.62% | -0.64% | -0.92% | 2.90% |
| Total Liabilities | -3.90% | -4.61% | -0.64% | -5.09% | 2.90% |
|
|
|||||
| Common Stock & APIC | -3.90% | 3.60% | -0.64% | -1.97% | 2.90% |
| Retained Earnings | -3.90% | -17.76% | -0.64% | 32.25% | 2.90% |
| Treasury Stock & Other | 3.90% | 46.13% | 0.64% | -92.71% | -2.90% |
| Total Common Equity | -3.90% | 0.81% | -0.64% | 5.84% | 2.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.90% | 0.81% | -0.64% | 5.84% | 2.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -3.90% | 20.76% | -0.64% | 18.38% | 2.90% |
| Total Equity | -3.90% | 5.20% | -0.64% | 8.37% | 2.90% |
|
|
|||||